OCIAD2 anticorps (AA 65-154)

N° du produit ABIN718031

L’anticorps anti-OCIAD2 Polyclonal Lapin est utilisé pour la détection de OCIAD2 dans des échantillons de Humain. Il a été validé pour WB, IHC (p), IF (cc), IF (p) et IHC (fro).

Aperçu rapide pour OCIAD2 anticorps (AA 65-154) (ABIN718031)

Antigène: OCIAD2 (OCIA Domain Containing 2 (OCIAD2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp OCIAD2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-OCIAD2 anticorps

Épitope: AA 65-154

Fonction: OCIAD2 Polyclonal Antibody

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human OCIAD2

Isotype: IgG

Information d'application

Indications d'application: WB(1:300-5000),

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur OCIAD2

Antigène: OCIAD2 (OCIA Domain Containing 2 (OCIAD2))

Autre désignation: OCIAD2

Sujet:

Synonyms: OCAD2_HUMAN, OCIA domain containing 2, OCIA domain-containing protein 2, OCIAD2, ovarian carcinoma immunoreactive antigen, Ovarian carcinoma immunoreactive antigen like protein, Ovarian carcinoma immunoreactive antigen-like protein.

Background: OCIAD2 was identified by its sequence similarity with OCIAD1, and together OCIAD1 and OCIAD2 form the OCIA domain family. While the function of OCIAD2 is still unknown, its expression in adenocarcinoma with BAC component is significantly associated with a favorable prognosis and may serve as a marker for selecting tumors that are treatable by limited surgery.

ID gène: 132299